Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISEDRONIC ACID vs RITLECITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISEDRONIC ACID vs RITLECITINIB: Safety Overview

Metric RISEDRONIC ACID RITLECITINIB
Total FAERS Reports 461 1,441
Deaths Reported 22 1
Death Rate 4.8% 0.1%
Hospitalizations 196 47
Average Patient Age 68.2 yrs 34.7 yrs
% Female Patients 92.2% 65.0%
FDA Approval Date N/A Jun 23, 2023
Manufacturer N/A U.S. Pharmaceuticals
Route N/A ORAL
Marketing Status N/A Prescription